Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal

Status Completed

Clinical Trial Summary

Alterations in the intrauterine environment can have profound effects on fetal development. Diabetes during gestation results in multiple deleterious short-term outcome differences, and is correlated with long-term developmental deficits. Multiple studies, in neonates through school-aged children, have demonstrated differences in language, attention and psychomotor development in offspring of diabetic pregnancies. Neonatal EEG is a promising and non-invasive tool for assessment of abnormal brain development or "dysmaturity" in this population. Multiple conventional EEG (cEEG) and amplitude-integrated EEG (aEEG) parameters change predictably with advancing gestational development and have been used to differentiate between at risk groups in neonatal studies.

The investigators hypothesize that neonatal EEG can identify brain dysmaturity in infants of diabetic mothers (IDMs) compared to gestational-age matched controls. The primary aim is documentation of brain dysmaturity in IDMs using cEEG. The secondary aim is establishment of aEEG as a more accessible tool to quantify the effects of maternal diabetes on neonatal brain development.

The investigators will conduct a pilot study comparing cEEG and aEEG parameters of cases to gestational-age matched controls. Cases will be IDM neonates of at least 35 weeks' gestation whose mothers were recommended treatment with either insulin or an oral glycemic agent. Video EEG recording will be planned for approximately 60 minutes and obtained between 24 hours and 5 days of life during birth hospitalization. Additional data will be extracted from maternal and neonatal medical records and a maternal questionnaire.

In addition to evaluating the measures of cEEG and aEEG, this project will establish a research cohort. A subsequent study involving developmental evaluations will allow for correlation of EEG results with long-term outcomes. The ability to identify those at risk at birth would provide the opportunity to intervene in order to mitigate outcome differences, particularly in language development. More significantly, we hope to establish neonatal CNS outcome measures for future diabetic pregnancy intervention studies. .

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Diabetes in Pregnancy
Diabetes Mellitus
Diabetes, Gestational
Infant, Newborn, Diseases
Perinatal Disorders of Growth and Development
Pregnancy in Diabetics

Clinical Trial Details

NCT number	NCT02968628
Study type	Observational
Source	University of Rochester
Contact
Status	Completed
Phase
Start date	September 1, 2016
Completion date	October 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02577536` - PregSource: Crowdsourcing to Understand Pregnancy
Completed	`NCT01940003` - Effects of an Aquatic Physical Exercise Program on Glycaemic Control and Perinatal Outcomes of Gestational Diabetes: Study Protocol for a Randomized Controlled Trial	N/A
Completed	`NCT02960295` - The Virtual Visit for Women With Gestational Diabetes	N/A
Completed	`NCT01919476` - Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women	N/A
Completed	`NCT05512871` - A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM)	N/A
Enrolling by invitation	`NCT03307486` - Gestational Diabetes: a Cohort Study	N/A
Active, not recruiting	`NCT04417452` - Long-term Outcome After Gestational Diabetes and Diabetes in Pregnancy
Active, not recruiting	`NCT04222348` - MeDiGes Study: Metformine Use in Gestational Diabetes	Phase 3
Completed	`NCT03007186` - Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus
Completed	`NCT00069576` - Gestational Diabetes Mellitus Trial (GDM)	N/A
Completed	`NCT04866823` - Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes	N/A
Recruiting	`NCT04198857` - Development and Testing of a Mobile Health Application for Management of Gestational Diabetes	N/A
Recruiting	`NCT05115188` - DIAgnosing GDM usiNg Oral Sugar InStead	Phase 2
Recruiting	`NCT03607799` - A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes	N/A
Recruiting	`NCT02893072` - Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study	N/A
Enrolling by invitation	`NCT05368220` - Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
Completed	`NCT02770079` - Insulin Sensitivity and Secretion During Pregnancy and Post Partum in Women With Gestational Diabetes.
Completed	`NCT00681460` - Metformin in Gestational Diabetes Mellitus	N/A
Recruiting	`NCT03117543` - Diagnostic Approaches in Gestational Diabetes and Impact of Ethnicity
Completed	`NCT02931656` - Acute Effects of an Aquatic Physical Exercise on Glycemic Control of Gestational Diabetes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms